Wei Gao
Michigan Cancer Research Consortium(US)University of Houston(US)
Publications by Year
Research Areas
Nanoparticle-Based Drug Delivery, RNA Interference and Gene Delivery, Nanoplatforms for cancer theranostics, Nutritional Studies and Diet, Advanced biosensing and bioanalysis techniques
Most-Cited Works
- → Why 90% of clinical drug development fails and how to improve it?(2022)1,450 cited
- → Structure-Based Design of Spiro-oxindoles as Potent, Specific Small-Molecule Inhibitors of the MDM2−p53 Interaction(2006)684 cited
- → Structure-Based Design of Potent Non-Peptide MDM2 Inhibitors(2005)644 cited
- → Structure-Based Design of Potent Small-Molecule Inhibitors of Anti-Apoptotic Bcl-2 Proteins(2006)294 cited
- → What Went Wrong with Anticancer Nanomedicine Design and How to Make It Right(2020)255 cited
- → Novel thermo-sensitive hydrogel system with paclitaxel nanocrystals: High drug-loading, sustained drug release and extended local retention guaranteeing better efficacy and lower toxicity(2013)207 cited